Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|January 13, 2025

Managed Care Partnerships and Continuity of Care

A panelist discusses how strategic managed care partnerships can streamline care transitions between treatment settings to ensure uninterrupted support and monitoring for patients with Lambert-Eaton myasthenic syndrome.

Episodes in this series

EP. 1 LEMS and SCLC: Unraveling the Neuromuscular-Cancer Connection

EP. 1 LEMS and SCLC: Unraveling the Neuromuscular-Cancer Connection

EP. 2 Strategies to Alleviate the Clinical and Economic Burden of LEMS

EP. 2 Strategies to Alleviate the Clinical and Economic Burden of LEMS

EP. 3 The Clinical and Economic Impact of LEMS in SCLC Care

EP. 3 The Clinical and Economic Impact of LEMS in SCLC Care

1 expert is featured in this series.

EP. 4 Using Technology for Early Detection of LEMS

1 expert is featured in this series.

EP. 5 Team- and System-Based Approaches to Managing LEMS and Ensuring Access

1 expert is featured in this series.

EP. 6 The Role of Patient Engagement Tools and Patient Advocacy Groups in LEMS Care

1 expert is featured in this series.

EP. 7 Managed Care Partnerships and Continuity of Care

Video content above is prompted by the following:

How can managed care partnerships enhance continuity of care for patients transitioning between different treatment settings?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Doctor phone call. | Image credit: @AndreyPopov_AdobeStock.jpeg

Voice Biomarkers Show Promise for Asthma, COPD Exacerbation Detection

BySabrina McCrear

July 16th 2026

Blue FDA approved stamp | Image credit: Surendra-stock.adobe.com

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

ByLaura Joszt, MA

July 16th 2026

Experts featured in this series.

Why Clinicians May Consider Obinutuzamab Over Rituximab in Follicular Lymphoma

ByRyan Haumschild, PharmD, MS, MBA, CPEL,Christina Poh, MD,Tara Graff DO, MS

July 16th 2026

Experts featured in this series.

Managing the Tafasitamab Triplet: Safety Profile, Adverse Events, and Clinical Implications from inMIND

ByRyan Haumschild, PharmD, MS, MBA, CPEL,Christina Poh, MD,Tara Graff DO, MS

July 16th 2026

Man using breathing assistant device. | Image credit: @DebraAnderson_AdobeStock.jpeg

Respiratory Rehabilitation Benefits Patients With COPD and Suspected PH

BySabrina McCrear

July 15th 2026

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

Home-Based Heart Failure Care Shows Comparable Safety to Continued Inpatient Care

Cardiology Prices Vary Widely by Insurer and State

Voice Biomarkers Show Promise for Asthma, COPD Exacerbation Detection

Rethinking Cardiometabolic Risk: Deepak Bhatt, MD, MPH, MBA